MYDA Advisors LLC acquired a new position in shares of MedTech Acquisition Co. (NASDAQ:MTAC) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 203,070 shares of the company’s stock, valued at approximately $1,962,000. MYDA Advisors LLC owned 0.74% of MedTech Acquisition as of its most recent filing with the Securities and Exchange Commission.
Separately, Chilton Investment Co. LLC bought a new position in shares of MedTech Acquisition during the 1st quarter worth about $193,000. Institutional investors and hedge funds own 47.06% of the company’s stock.
Shares of NASDAQ:MTAC traded up $0.02 on Friday, hitting $9.90. 71,627 shares of the company were exchanged, compared to its average volume of 58,061. The firm’s 50 day moving average price is $9.80. MedTech Acquisition Co. has a one year low of $9.45 and a one year high of $11.18.
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Further Reading: How accurate is the Rule of 72?
Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.